HuGE Literature Finder
Records
1
-
3
Clinical Value of Pharmacogenomic Testing in a Patient Receiving FOLFIRINOX for Pancreatic Adenocarcinoma. Frontiers in pharmacology 2018 9 1309. Velez-Velez Lisa M, Hughes Caren L, Kasi Pashtoon Murta |
Molecular Markers for the Prediction of Minor Response to Neoadjuvant Chemoradiation in Esophageal Cancer: Results of the Prospective Cologne Esophageal Response Prediction (CERP) Study. Annals of surgery 2016 Nov 264 (5): 839-846. Bollschweiler Elfriede, Hölscher Arnulf H, Herbold Till, Metzger Ralf, Alakus Hakan, Schmidt Henner, Drebber Uta, Warnecke-Eberz U |
Discovery of novel mutations in the dihydropyrimidine dehydrogenase gene associated with toxicity of fluoropyrimidines and viewpoint on preemptive pharmacogenetic screening in patients. The EPMA journal 2015 6 (1): 17. Del Re Marzia, Michelucci Angela, Di Leo Angelo, Cantore Maurizio, Bordonaro Roberto, Simi Paolo, Danesi Roma |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 26, 2023
- Content source: